For: | Sousa AGP, Cabral JVS, El-Feghaly WB, Sousa LS, Nunes AB. Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management. World J Diabetes 2016; 7(5): 101-111 [PMID: 26981183 DOI: 10.4239/wjd.v7.i5.101] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v7/i5/101.htm |
Number | Citing Articles |
1 |
Josep Redon, Fernando Martinez. Blood Pressure Disorders in Diabetes Mellitus. Updates in Hypertension and Cardiovascular Protection 2023; : 39 doi: 10.1007/978-3-031-13009-0_3
|
2 |
Murat Özdede, Alper Tuna Güven. Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment. Internal and Emergency Medicine 2024; 19(3): 879 doi: 10.1007/s11739-023-03520-4
|
3 |
Johannes Leiner, Vincent Pellissier, Sebastian König, Lars Stellmacher, Sven Hohenstein, Carolin Schanner, Stefan Kwast, Ralf Kuhlen, Andreas Bollmann. Patient Characteristics and Outcomes of Hospitalized Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus: Observations from the German Claims Data-Based Cohort of the CaReMe-CKD Multinational Study. Clinical Epidemiology 2024; : 487 doi: 10.2147/CLEP.S459767
|
4 |
Hiroki Yamaguchi, Michihiro Hosojima, Hideyuki Kabasawa, Yumi Ito, Yoshiki Suzuki, Akihiko Saito, Masaaki Arakawa, Ichiei Narita. A case of idiopathic nodular glomerulosclerosis successfully treated by intensive blockade of the renin–angiotensin–aldosterone system. CEN Case Reports 2022; 12(3): 311 doi: 10.1007/s13730-022-00766-3
|
5 |
Zubaid Rafique, Maria José Fortuny, Dick Kuo, Lukasz Szarpak, Lluís Llauger, Begoña Espinosa, Víctor Gil, Javier Jacob, Aitor Alquézar-Arbé, Juan Antonio Andueza, José Manuel Garrido, Alfons Aguirre, Marta Fuentes, Héctor Alonso, Francisco Javier Lucas-Imbernón, Carlos Bibiano, Guillermo Burillo-Putze, Julio Núñez, Wilfried Mullens, Pedro Lopez-Ayala, Christian Mueller, Pere Llorens, Frank Peacock, Òscar Miró. Hyperkalemia in acute heart failure: Short term outcomes from the EAHFE registry. The American Journal of Emergency Medicine 2023; 70: 1 doi: 10.1016/j.ajem.2023.05.005
|
6 |
John William Honour. Steroids in the Laboratory and Clinical Practice. 2023; : 935 doi: 10.1016/B978-0-12-818124-9.00021-8
|
7 |
Christian A. Koch, Tibor Fulop. Clinical aspects of changes in water and sodium homeostasis in the elderly. Reviews in Endocrine and Metabolic Disorders 2017; 18(1): 49 doi: 10.1007/s11154-017-9420-5
|
8 |
Eugenia Gkaliagkousi, Panagiota Anyfanti, Antonios Lazaridis, Stella Douma. Plasma renin activity to plasma aldosterone concentration ratio for the assessment of essential hypertensive patients in real-life clinical practice. Journal of Hypertension 2018; 36(2): 444 doi: 10.1097/HJH.0000000000001630
|
9 |
Silvia Matino, Francesco Pesce, Michele Rossini, Giuseppina D’Ettorre, Alessandro Mascolo, Loreto Gesualdo. Thyroid Diseases. Endocrinology 2019; : 1 doi: 10.1007/978-3-319-66362-3_5-1
|
10 |
Marion Walker, Hari Vivekanantham, Denis Graf. ECG of the month: A “de Winter”-like ECG pattern in a patient presenting with progressive lethargy. Annals of Emergency Medicine 2021; 77(4): 445 doi: 10.1016/j.annemergmed.2020.09.434
|
11 |
Jorge Gabriel Ruiz-Sánchez, Alfonso Luis Calle-Pascual, Miguel Ángel Rubio-Herrera, María Paz De Miguel Novoa, Emilia Gómez-Hoyos, Isabelle Runkle. Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.990148
|
12 |
Bianca Domingues Massolini, Stephanie San Gregorio Contieri, Giulia Severini Lazarini, Paula Antoun Bellacosa, Mirela Dobre, Georg Petroianu, Andrei Brateanu, Luciana Aparecida Campos, Ovidiu Constantin Baltatu. Therapeutic Renin Inhibition in Diabetic Nephropathy—A Review of the Physiological Evidence. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00190
|
13 |
Pasquale Esposito, Novella Evelina Conti, Valeria Falqui, Leda Cipriani, Daniela Picciotto, Francesca Costigliolo, Giacomo Garibotto, Michela Saio, Francesca Viazzi. New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease. Journal of Clinical Medicine 2020; 9(8): 2337 doi: 10.3390/jcm9082337
|
14 |
Rehab B. Albakr, Vikas S. Sridhar, David Z.I. Cherney. Novel Therapies in Diabetic Kidney Disease and Risk of Hyperkalemia: A Review of the Evidence From Clinical Trials. American Journal of Kidney Diseases 2023; 82(6): 737 doi: 10.1053/j.ajkd.2023.04.015
|
15 |
Kleber Goia-Nishide, Lucas Coregliano-Ring, Érika Bevilaqua Rangel. Hyperkalemia in Diabetes Mellitus Setting. Diseases 2022; 10(2): 20 doi: 10.3390/diseases10020020
|
16 |
Samuel Sherng Young Wang, Haoming Tang, Wen Qi Jane Ho, Sharen Asif, Yi Xin Li, Adel Ekladious, Muhammad M Javaid. Understanding renal tubular acidosis. British Journal of Hospital Medicine 2024; : 1 doi: 10.12968/hmed.2024.0290
|
17 |
Javier Morales, Biff F. Palmer. Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review. Postgraduate Medicine 2024; 136(2): 111 doi: 10.1080/00325481.2024.2316572
|
18 |
Gadi Shlomai, Anat Berkovitch, Shiran Pinchevski-Kadir, Gil Bornstein, Avshalom Leibowitz, Ilan Goldenberg, Ehud Grossman. The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomes. Medicine 2016; 95(23): e3778 doi: 10.1097/MD.0000000000003778
|
19 |
Masanori Adachi, Sakura Motegi, Keiko Nagahara, Ayako Ochi, Junya Toyoda, Katsumi Mizuno. Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature review. Endocrine Journal 2023; 70(7): 723 doi: 10.1507/endocrj.EJ22-0607
|
20 |
|
21 |
Anna Marco-Ramell, Sara Tulipani, Magali Palau-Rodriguez, Raul Gonzalez-Dominguez, Antonio Miñarro, Olga Jauregui, Alex Sanchez-Pla, Manuel Macias-Gonzalez, Fernando Cardona, Francisco J. Tinahones, Cristina Andres-Lacueva. Untargeted Profiling of Concordant/Discordant Phenotypes of High Insulin Resistance and Obesity To Predict the Risk of Developing Diabetes. Journal of Proteome Research 2018; 17(7): 2307 doi: 10.1021/acs.jproteome.7b00855
|
22 |
Satoru Kuriyama. A Potential Mechanism of Cardio-Renal Protection with Sodium-Glucose Cotransporter 2 Inhibitors: Amelioration of Renal Congestion. Kidney and Blood Pressure Research 2019; 44(4): 449 doi: 10.1159/000501081
|
23 |
Robert W Hunter, Matthew A Bailey. Hyperkalemia: pathophysiology, risk factors and consequences. Nephrology Dialysis Transplantation 2019; 34(Supplement_3): iii2 doi: 10.1093/ndt/gfz206
|
24 |
Gladness Dakalo Nethathe, Jeremy Cohen, Jeffrey Lipman, Ronald Anderson, Charles Feldman. Mineralocorticoid Dysfunction during Critical Illness. Anesthesiology 2020; 133(2): 439 doi: 10.1097/ALN.0000000000003365
|
25 |
Shrey Purohit, Dalila B. Corry, Michael L. Tuck. Encyclopedia of Endocrine Diseases. 2018; : 703 doi: 10.1016/B978-0-12-801238-3.95898-7
|
26 |
Su‐Min Park, Ju‐Hyun An, Na‐Hyeong Kim, Ye‐In Oh, Kyoung‐won Seo, Hwa‐Young Youn. Isolated hypoaldosteronism managed by DOCP in a dog with chronic kidney disease and hypercortisolism. Veterinary Medicine and Science 2022; 8(6): 2292 doi: 10.1002/vms3.954
|
27 |
Jodi D. Stookey, Prasanna K.R. Allu, Dorothee Chabas, David Pearce, Florian Lang. Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19. Medical Hypotheses 2020; 144: 110237 doi: 10.1016/j.mehy.2020.110237
|
28 |
Febriana M Puspita, Em Yunir, Putri S Agustina, Rani Sauriasari. Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3841 doi: 10.2147/DMSO.S310091
|
29 |
Jennifer E. Clark, Jaime de la Fuente, Luke T. Hafdahl. 66-Year-Old Man With Light-headedness, Chest Pain, and Dyspnea. Mayo Clinic Proceedings 2019; 94(2): e13 doi: 10.1016/j.mayocp.2018.04.030
|
30 |
Marco Quaglia, Guido Merlotti, Vincenzo Cantaluppi. Renal tubular acidosis. Giornale di Tecniche Nefrologiche e Dialitiche 2016; 28(3): 157 doi: 10.5301/GTND.2016.15989
|
31 |
Vincenzo Panuccio, Daniela Leonardis, Rocco Tripepi, Maria Carmela Versace, Claudia Torino, Giovanni Tripepi, Graziella D’Arrigo, Francesca Mallamaci, Carmine Zoccali. Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study. Internal and Emergency Medicine 2021; 16(7): 1803 doi: 10.1007/s11739-021-02653-8
|
32 |
Isao Kurihara. IV. Endocrine Disorders Associated with Hyperkalemia. Nihon Naika Gakkai Zasshi 2020; 109(4): 727 doi: 10.2169/naika.109.727
|
33 |
S. J. H. Dobbin, J. R. Petrie, M. E. J. Lean, G. A. McKay. Fludrocortisone therapy for persistent hyperkalaemia. Diabetic Medicine 2017; 34(7): 1005 doi: 10.1111/dme.13359
|
34 |
N.O. Pertseva, T.V. Chursinova, A.A. Gryshniakova. Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2023; 19(2): 149 doi: 10.22141/2224-0721.19.2.2023.1261
|
35 |
John D. Firth, John D. Firth. Oxford Textbook of Medicine. 2020; doi: 10.1093/med/9780198746690.003.0474
|
36 |
Alper Tuna Güven, Murat Özdede, Yusuf Ziya Şener, Ali Osman Yıldırım, Sabri Engin Altıntop, Berkay Yeşilyurt, Oğuz Abdullah Uyaroğlu, Mine Durusu Tanrıöver. Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction. European Journal of Internal Medicine 2023; 114: 74 doi: 10.1016/j.ejim.2023.05.021
|
37 |
Kohei Okamoto, Hideki Fujii, Kentaro Watanabe, Shunsuke Goto, Keiji Kono, Shinichi Nishi. Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy. Journal of the Endocrine Society 2022; 6(2) doi: 10.1210/jendso/bvab187
|
38 |
Silvio Borrelli, Luca De Nicola, Roberto Minutolo, Giuseppe Conte, Paolo Chiodini, Adamasco Cupisti, Domenico Santoro, Vincenzo Calabrese, Domenico Giannese, Carlo Garofalo, Michele Provenzano, Vincenzo Bellizzi, Luca Apicella, Giorgina Barbara Piccoli, Massimo Torreggiani, Biagio Raffaele Di Iorio. Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care. Nutrients 2021; 13(3): 942 doi: 10.3390/nu13030942
|
39 |
O. Voloshchuk, I. Lungul, G. Kopylchuk. INDICATORS OF WATER-SALT ВALANCE IN ANIMALS UNDER CONDITIONS OF DIFFERENT
NUTRIENT SUPPLY. Biolohichni systemy 2021; 13(1) doi: 10.31861/biosystems2021.01.003
|
40 |
Chia-Hui Chang, Ya-Hui Hu, Kuo-How Huang, Yen-Hung Lin, Yao-Chou Tsai, Che-Hsiung Wu, Shao-Yu Yang, Chin-Chen Chang, Ching-Chu Lu, Kwan-Dun Wu, Vin-Cent Wu. Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus. Journal of Clinical Medicine 2018; 7(10): 360 doi: 10.3390/jcm7100360
|
41 |
Davide Costa, Gemma Patella, Michele Provenzano, Nicola Ielapi, Teresa Faga, Mariateresa Zicarelli, Franco Arturi, Giuseppe Coppolino, Davide Bolignano, Giovambattista De Sarro, Umberto Marcello Bracale, Luca De Nicola, Paolo Chiodini, Raffaele Serra, Michele Andreucci. Hyperkalemia in CKD: an overview of available therapeutic strategies. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1178140
|
42 |
Jamala Mammadova, Cengiz Kara, Eda Çelebi Bitkin, Elif İzci Güllü, Murat Aydın. Nephrogenic Syndrome of Inappropriate Antidiuresis Mimicking Hyporeninemic Hypoaldosteronism: Case Report of Two Infants. Journal of Clinical Research in Pediatric Endocrinology 2023; 15(2): 214 doi: 10.4274/jcrpe.galenos.2021.2021.0191
|
43 |
A. V. Semenko, Y. V. Murdasov, S. V. Kirichenko, V. I. Zhyliuk, G. A. Ushakovа. Influence of melatonin on the kidneys of rats with experimental diabetes mellitus type 2. Regulatory Mechanisms in Biosystems 2020; 11(3): 384 doi: 10.15421/022059
|
44 |
Sara Erraez, Manuel López-Mesa, Pablo Gómez-Fernández. Mineralcorticoid receptor blockers in chronic kidney disease. Nefrología (English Edition) 2021; 41(3): 258 doi: 10.1016/j.nefroe.2021.08.001
|
45 |
Masahiro Takubo, Sho Tanaka, Masaru Kushimoto, Jin Ikeda, Katsuhiko Ogawa, Yutaka Suzuki, Masanori Abe, Hisamitsu Ishihara, Midori Fujishiro. Hyponatremia Associated with Prophylactic Low-Dose Trimethoprim during Systemic Corticosteroid Therapy for AQP4-Positive Optic Neuritis in a Diabetic Patient. Antibiotics 2020; 9(4): 201 doi: 10.3390/antibiotics9040201
|
46 |
Thierry Hannedouche, Patrick Rossignol, Patrice Darmon, Jean-Michel Halimi, Patrick Vuattoux, Albert Hagege, Ludivine Videloup, Francis Guinard. Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations. Postgraduate Medicine 2023; 135(7): 633 doi: 10.1080/00325481.2023.2256208
|
47 |
Sara Erraez, Manuel López-Mesa, Pablo Gómez-Fernández. Bloqueantes del receptor mineralcorticoide en la enfermedad renal crónica. Nefrología 2021; 41(3): 258 doi: 10.1016/j.nefro.2020.10.001
|
48 |
Silvia Matino, Francesco Pesce, Michele Rossini, Giuseppina D’Ettorre, Alessandro Mascolo, Loreto Gesualdo. Endocrinology and Systemic Diseases. Endocrinology 2021; : 123 doi: 10.1007/978-3-319-68729-2_5
|
49 |
Satoru Kuriyama. Protection of the kidney with sodium–glucose cotransporter 2 inhibitors: potential mechanisms raised by the large-scaled randomized control trials. Clinical and Experimental Nephrology 2019; 23(3): 304 doi: 10.1007/s10157-018-1673-0
|
50 |
Christiane I Ramos, Ailema González-Ortiz, Angeles Espinosa-Cuevas, Carla M Avesani, Juan Jesus Carrero, Lilian Cuppari. Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?. Nephrology Dialysis Transplantation 2021; 36(11): 2049 doi: 10.1093/ndt/gfaa232
|
51 |
Ahmed Abdelaal Ahmed Mahmoud, Mark Campbell, Margarita Blajeva. Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?. Case Reports in Anesthesiology 2018; 2018: 1 doi: 10.1155/2018/1852016
|
52 |
K. V. Skobeleva, L. V. Tyrtova. The effect of the components of the renin-angiotensinaldosterone system on the development of diabetic nephropathy in type 1 diabetes (review). Nephrology (Saint-Petersburg) 2021; 25(2): 43 doi: 10.36485/1561-6274-2021-25-2-43-51
|
53 |
|
54 |
Masanori Adachi, Keiko Nagahara, Ayako Ochi, Junya Toyoda, Koji Muroya, Katsumi Mizuno. Acid–Base Imbalance in Pseudohypoaldosteronism Type 1 in Comparison With Type IV Renal Tubular Acidosis. Journal of the Endocrine Society 2022; 6(12) doi: 10.1210/jendso/bvac147
|
55 |
|
56 |
Antoine-Guy Lopez, Céline Duparc, Julien Wils, Alexandre Naccache, Mireille Castanet, Hervé Lefebvre, Estelle Louiset. Steroidogenic cell microenvironment and adrenal function in physiological and pathophysiological conditions. Molecular and Cellular Endocrinology 2021; 535: 111377 doi: 10.1016/j.mce.2021.111377
|
57 |
Vandana S Mathur, Elizabeth Li, Donald E Wesson. Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial. Nephrology Dialysis Transplantation 2022; 37(7): 1302 doi: 10.1093/ndt/gfab209
|
58 |
Toshiyuki Yano, Satoshi Katano, Hidemichi Kouzu, Ryohei Nagaoka, Takuya Inoue, Yuhei Takamura, Tomoyuki Ishigo, Ayako Watanabe, Katsuhiko Ohori, Masayuki Koyama, Nobutaka Nagano, Takefumi Fujito, Ryo Nishikawa, Akiyoshi Hashimoto, Tetsuji Miura. Distinct determinants of muscle wasting in nonobese heart failure patients with and without type 2 diabetes mellitus. Journal of Diabetes 2021; 13(1): 7 doi: 10.1111/1753-0407.13090
|
59 |
Gregory L. Hundemer, Manish M. Sood. Hyperkalemia with RAAS inhibition: Mechanism, clinical significance, and management. Pharmacological Research 2021; 172: 105835 doi: 10.1016/j.phrs.2021.105835
|
60 |
Laurence Lepage, Katherine Desforges, Jean-Philippe Lafrance. New drugs to prevent and treat hyperkalemia. Current Opinion in Nephrology and Hypertension 2016; 25(6): 524 doi: 10.1097/MNH.0000000000000272
|
61 |
Yanru Wang, Yuxing Chen, Yanping Yu, Xin Pan, Guoxiang Fu. Association of urinary calcium excretion with chronic kidney disease in patients with type 2 diabetes. International Urology and Nephrology 2024; 56(8): 2715 doi: 10.1007/s11255-024-03978-x
|
62 |
Gürkan Tarçın, Saffa Ahmadzada, Seha Saygılı, Ayşem Kaya, Ayşe Çiğdem Aktuğlu Zeybek, Oya Ercan. Evaluating renin and aldosterone levels in children with organic acidemia—therapeutic experience with fludrocortisone. European Journal of Pediatrics 2023; 182(12): 5447 doi: 10.1007/s00431-023-05221-8
|
63 |
Manju Gauri Kunchur, Teri Jo Mauch, Max Parkanzky, Louisa J. Rahilly. A review of renal tubular acidosis. Journal of Veterinary Emergency and Critical Care 2024; 34(4): 325 doi: 10.1111/vec.13407
|
64 |
David S. Goldfarb, Jon-Emile S. Kenny. Nephrology Secrets. 2019; : 549 doi: 10.1016/B978-0-323-47871-7.00087-3
|